These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 28735628)

  • 21. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.
    Brennan DJ; Hackethal A; Mann KP; Mutz-Dehbalaie I; Fiegl H; Marth C; Obermair A
    BMC Cancer; 2015 Feb; 15():33. PubMed ID: 25655024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MMP3 in Comparison to CA 125, HE4 and the ROMA Algorithm in Differentiation of Ovarian Tumors.
    Cymbaluk-Ploska A; Chudecka-Glaz A; Surowiec A; Pius-Sadowska E; Machalinski B; Menkiszak J
    Asian Pac J Cancer Prev; 2016; 17(5):2597-603. PubMed ID: 27268637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome.
    Zanotti L; Bignotti E; Calza S; Bandiera E; Ruggeri G; Galli C; Tognon G; Ragnoli M; Romani C; Tassi RA; Caimi L; Odicino FE; Sartori E; Pecorelli S; Ravaggi A
    Clin Chem Lab Med; 2012 Dec; 50(12):2189-98. PubMed ID: 23096757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
    Prueksaritanond N; Cheanpracha P; Yanaranop M
    Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of HE4 in differentiating benign and malignant endometrial pathology.
    Gąsiorowska E; Magnowska M; Iżycka N; Warchoł W; Nowak-Markwitz E
    Ginekol Pol; 2016; 87(4):260-4. PubMed ID: 27321096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum human epididymis protein 4 vs. carbohydrate antigen 125 and their combination for endometrial cancer diagnosis: a meta-analysis.
    Chen Y; Ren YL; Li N; Yi XF; Wang HY
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):1974-85. PubMed ID: 27249595
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emerging role of HE4 in the evaluation of epithelial ovarian and endometrial carcinomas.
    Simmons AR; Baggerly K; Bast RC
    Oncology (Williston Park); 2013 Jun; 27(6):548-56. PubMed ID: 23909069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The values of serum human epididymis secretory protein 4 and CA(125) assay in the diagnosis of ovarian malignancy].
    Dong L; Chang XH; Ye X; Zhu LR; Zhao Y; Tian L; Cheng HY; Li XP; Zhang H; Liao QP; Fu TY; Cheng YX; Cui H
    Zhonghua Fu Chan Ke Za Zhi; 2008 Dec; 43(12):931-6. PubMed ID: 19134334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
    Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
    Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of human epididymis secretory protein E4 in patients with endometrial cancer and premalignant endometrial lesions.
    Yılmaz SA; Altınkaya SÖ; Kerimoglu ÖS; Tazegül Pekin A; Akyürek F; Ilhan TT; Benzer N; Unlu A; Yuksel H; Celik C
    J Obstet Gynaecol; 2017 Jan; 37(1):58-63. PubMed ID: 28006994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus.
    Moore RG; Brown AK; Miller MC; Badgwell D; Lu Z; Allard WJ; Granai CO; Bast RC; Lu K
    Gynecol Oncol; 2008 Aug; 110(2):196-201. PubMed ID: 18495222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Espiau Romera A; Coronado Martín PJ; Chóliz Ezquerro M; Cuesta Guardiola T; Adiego Calvo I; Baquedano Mainar L
    Int J Gynaecol Obstet; 2021 Apr; 153(1):64-70. PubMed ID: 33156532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study.
    Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HE4 is an independent prognostic marker in endometrial cancer patients.
    Mutz-Dehbalaie I; Egle D; Fessler S; Hubalek M; Fiegl H; Marth C; Widschwendter A
    Gynecol Oncol; 2012 Aug; 126(2):186-91. PubMed ID: 22525819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnostic role of human epididymis protein 4 and serum amyloid-A in early-stage endometrial cancer patients.
    Omer B; Genc S; Takmaz O; Dirican A; Kusku-Kiraz Z; Berkman S; Gurdol F
    Tumour Biol; 2013 Oct; 34(5):2645-50. PubMed ID: 23640061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Models including plasma levels of sphingomyelins and phosphatidylcholines as diagnostic and prognostic biomarkers of endometrial cancer.
    Knific T; Vouk K; Smrkolj Š; Prehn C; Adamski J; Rižner TL
    J Steroid Biochem Mol Biol; 2018 Apr; 178():312-321. PubMed ID: 29360580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further insight into prognostic factors in endometrial cancer: the new serum biomarker HE4.
    Capriglione S; Plotti F; Miranda A; Lopez S; Scaletta G; Moncelli M; Luvero D; De Cicco Nardone C; Terranova C; Montera R; Angioli R
    Expert Rev Anticancer Ther; 2017 Jan; 17(1):9-18. PubMed ID: 27892774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of circulating tumour cells may add value in endometrial cancer management.
    Ni T; Sun X; Shan B; Wang J; Liu Y; Gu SL; Wang YD
    Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():1-4. PubMed ID: 27756035
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses.
    Abdel-Azeez HA; Labib HA; Sharaf SM; Refai AN
    Asian Pac J Cancer Prev; 2010; 11(1):111-6. PubMed ID: 20593939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.